Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients.
about
Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentMyeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implicationsRegulation of tumor metastasis by myeloid-derived suppressor cellsTargeting Immune Regulatory Networks to Counteract Immune Suppression in CancerMonitoring of the Immune Dysfunction in Cancer PatientsMapping the immunosuppressive environment in uterine tumors: implications for immunotherapy.Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.NOX2-dependent regulation of inflammationComputational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes.Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesIL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patientsMolecular pathways: myeloid complicity in cancer.Tumor-induced myeloid dysfunction and its implications for cancer immunotherapyExosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma.Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinomaIL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphomaYeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and ExtentMonocytic myeloid-derived suppressor cells as a potent suppressor of tumor immunity in non-small cell lung cancer.Myeloid-derived suppressor cells in gliomas.Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells.Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses.Myeloid-derived suppressor cell heterogeneity in human cancers.T-cell-mediated antitumor immunity in B-cell non-Hodgkin lymphoma: activation, suppression and exhaustion.Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer.Functional analysis of CD14+HLA-DR-/low myeloid-derived suppressor cells in patients with lung squamous cell carcinoma.Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome.A clinical and biological perspective of human myeloid-derived suppressor cells in cancer.Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges.On the origin of myeloid-derived suppressor cells.IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer.GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells in vitro.Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy.Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.Ascites-derived IL-6 and IL-10 synergistically expand CD14+HLA-DR-/low myeloid-derived suppressor cells in ovarian cancer patients.
P2860
Q26799126-0C4E8CDA-8270-4FFB-8620-3D0F09CDB2B3Q27014189-E1323BCE-B4F0-4469-8D4F-18577D67C584Q27022125-788B9CD6-0568-49D4-817F-9751AFC140C7Q28066486-8BBEFFFE-7F75-46AE-9BF8-9B9E04938301Q28072712-C81B0772-1134-4B6E-9384-17E242000224Q30578330-3DDC451F-E7A1-4DDE-BB25-6360A5AE04E6Q33429758-7FCEF42A-1899-47C0-A824-11362F70CFAFQ33849679-93FD2C66-350C-4670-9E66-026955D370CFQ33911333-624DCB95-527A-4433-9F07-A9FC013E7B4BQ34016867-20ADDAEA-E3F1-4592-B97A-0515BA40F793Q34044797-D71FE1C2-0D24-48A7-BB58-A0A45AE72864Q34483744-5DCA8F90-278E-49C1-9376-468982D82F0BQ34570094-C9E5256D-1F54-477F-BAAF-9DEFD070E4CCQ34725969-BD73367E-3C82-479E-81BC-B291695220F1Q34810257-0953CC90-BEE1-4C35-9CA4-76F9DD2879A0Q35143602-D547BD9A-7380-4F73-A201-0A142A20C622Q35889547-A3B58217-52A0-4ADB-83A9-AE994A286D3EQ35921894-3FF92D94-68BD-400E-9943-F72F3D4C499BQ36600997-EF323992-542B-4847-8605-49C73F30D08CQ36683267-82224DF8-D59D-40D0-BF2C-E3B4CC7C47B8Q37581919-2AB27084-6087-4720-8CB1-EFBD56BAD1FAQ37727645-628CCCE3-8466-466C-BBD2-9620FFE7C9E9Q38185156-A12A6B0F-9E27-47FD-9829-E9D93EF75DC2Q38193589-31853517-EC60-4595-BFE0-FCECF8287C0FQ38207587-D79B53A0-1A41-4925-8FB9-7A93F3889D74Q38223250-BF5EBF9F-24E9-43A1-9B39-F6BDB61B1617Q38344066-53410835-6ED1-4659-A4A4-5E1BC3DDAD15Q38528814-71DCD2B7-BEA2-4DDA-A3A9-C7CFA1A18FA1Q38697689-08311C08-3982-4D96-A319-79444C692325Q38702891-645DF2D3-5247-463F-9B03-4E4A26038C5EQ38820842-42D01663-3A1E-44D1-A223-610EC32EDFEFQ38847251-62CA6A68-0251-49ED-B2DD-3319D61792E2Q38958680-8C25008D-71C3-4738-8C44-5F8F339DF436Q38968944-9674DDB0-E01E-4FB9-B702-6E6F9C118ED0Q39613201-2A657474-AEB4-4368-80F1-96621EDA0725Q40032613-6CF5BEA4-5F21-498D-B156-E04C78C3A78EQ40148008-2FDD2C86-0737-42BD-A667-D051CD6F50A6Q42288627-45EF5F1C-BCF3-487A-9033-560142E1CEA1Q43100151-EB8AC82A-F84E-4757-9C71-E3BB2EBBA804Q45813459-A725A50C-6B5F-4858-9820-3B2A7ABD85D1
P2860
Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Increased CD14
@nl
Increased CD14(+)HLA-DR (-/low ...... all cell lung cancer patients.
@en
type
label
Increased CD14
@nl
Increased CD14(+)HLA-DR (-/low ...... all cell lung cancer patients.
@en
prefLabel
Increased CD14
@nl
Increased CD14(+)HLA-DR (-/low ...... all cell lung cancer patients.
@en
P2093
P2860
P1476
Increased CD14(+)HLA-DR (-/low ...... all cell lung cancer patients.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00262-013-1450-6
P577
2013-06-13T00:00:00Z
P6179
1014076313